ACP
Acuta Capital Partners Portfolio holdings
AUM
$71.6M
This Quarter Return
+9.48%
1 Year Return
+169.78%
3 Year Return
+1,553.75%
5 Year Return
+4,509.01%
10 Year Return
+155,159.98%
AUM
$153M
AUM Growth
+$153M
(+37%)
Cap. Flow
+$42.2M
Cap. Flow
% of AUM
27.59%
Top 10 Holdings %
Top 10 Hldgs %
56.26%
Holding
71
New
20
Increased
16
Reduced
11
Closed
16
Top Buys
| 1 |
AGTC
Applied Genetic Technologies Corporation
AGTC
|
$11.5M |
| 2 |
Veracyte
VCYT
|
$8.89M |
| 3 |
SPNC
Spectranetics Corp
SPNC
|
$5.75M |
| 4 |
AGEN
Agenus
AGEN
|
$3.83M |
| 5 |
SRNE
Sorrento Therapeutics, Inc.
SRNE
|
$3.74M |
Top Sells
| 1 |
CEMP
Cempra, Inc.
CEMP
|
$5.34M |
| 2 |
PTX
Pernix Therapeutics Holdings, Inc.
PTX
|
$3.74M |
| 3 |
Insmed
INSM
|
$3.12M |
| 4 |
Amicus Therapeutics
FOLD
|
$2.68M |
| 5 |
LeMaitre Vascular
LMAT
|
$2.61M |
Sector Composition
| 1 | Healthcare | 85.83% |
| 2 | Consumer Discretionary | 2.09% |
| 3 | Industrials | 0.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Larimar Therapeutics
LRMR
$310M
| $1.83M | 1.13% | 52,900 -47,100 | -47% | -$1.63M |
|
27
Cidara Therapeutics
CDTX
$1.66B
| $1.82M | 1.13% | +130,000 | New | +$1.82M |
|
28
Aurinia Pharmaceuticals
AUPH
$1.58B
| $1.59M | 0.98% | 524,751 +94,751 | +22% | +$286K |
|
29
Salarius Pharmaceuticals
SLRX
$2.94M
| $1.53M | 0.94% | 88,716 -1,284 | -1% | -$22.1K |
|
|
CBMX
30
DELISTED
CombiMatrix Corporation
CBMX
| $1.42M | 0.88% | 880,244 | – | – |
|
|
EGOV
31
DELISTED
NIC Inc
EGOV
| $1.28M | 0.79% | 70,000 +12,857 | +22% | +$235K |
|
|
OTIC
32
DELISTED
Otonomy, Inc.
OTIC
| $1.23M | 0.76% | 53,400 +33,400 | +167% | +$768K |
|
|
CUTR
33
DELISTED
Cutera, Inc.
CUTR
| $1.16M | 0.72% | +75,000 | New | +$1.16M |
|
34
Humana
HUM
$36.5B
| $1.15M | 0.71% | +6,000 | New | +$1.15M |
|
|
AGRX
35
DELISTED
Agile Therapeutics, Inc
AGRX
| $1.1M | 0.68% | 128,566 +47,607 | +59% | +$409K |
|
|
CRDC
36
DELISTED
CARDICA INC COM NEW (DE)
CRDC
| $923K | 0.57% | 1,849,436 +30,000 | +2% | +$15K |
|
37
Ocugen
OCGN
$319M
| $796K | 0.49% | 123,249 | – | – |
|
|
AWAY
38
DELISTED
HOMEAWAY INC COM
AWAY
| $778K | 0.48% | +25,000 | New | +$778K |
|
|
ARAV
39
DELISTED
Aravive, Inc. Common Stock
ARAV
| $761K | 0.47% | +50,000 | New | +$761K |
|
|
SGNT
40
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| $681K | 0.42% | +28,000 | New | +$681K |
|
|
CEMI
41
DELISTED
Chembio diagnostics, Inc.
CEMI
| $638K | 0.39% | 130,000 -16,099 | -11% | -$79K |
|
|
ZSAN
42
DELISTED
Zosano Pharma Corporation
ZSAN
| $632K | 0.39% | 87,189 +65,233 | +297% | +$473K |
|
|
ADAP
43
Adaptimmune Therapeutics
ADAP
$15.6M
| $550K | 0.34% | +30,000 | New | +$550K |
|
|
CEMP
44
DELISTED
Cempra, Inc.
CEMP
| $515K | 0.32% | 15,000 -155,400 | -91% | -$5.34M |
|
|
KIN
45
DELISTED
Kindred Biosciences, Inc.
KIN
| $341K | 0.21% | 50,000 -25,000 | -33% | -$171K |
|
|
FOMX
46
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $308K | 0.19% | +30,000 | New | +$308K |
|
47
Semler Scientific
SMLR
$439M
| $267K | 0.17% | 80,935 -34,213 | -30% | -$113K |
|
|
MOLG
48
DELISTED
MOL GLOBAL INC SPONSORED ADR
MOLG
| $226K | 0.14% | 147,912 -98,097 | -40% | -$150K |
|
49
AngioDynamics
ANGO
$417M
| – | – | -10,000 | Closed | -$178K |
|
50
Cerus
CERS
$251M
| – | – | -100,000 | Closed | -$417K |
|